Immunome's total assets for Q3 2025 were $299.38M, an increase of 1.04% from the previous quarter. IMNM total liabilities were $35.46M for the fiscal quarter, a 31.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.